GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Deferred Tax

Daito Pharmaceutical Co (TSE:4577) Deferred Tax : 円0 Mil (TTM As of Feb. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Daito Pharmaceutical Co Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Daito Pharmaceutical Co's change in deferred tax for the three months ended in Feb. 2024 was 円0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Feb. 2024 was 円0 Mil.

Daito Pharmaceutical Co Deferred Tax Historical Data

The historical data trend for Daito Pharmaceutical Co's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daito Pharmaceutical Co Deferred Tax Chart

Daito Pharmaceutical Co Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Daito Pharmaceutical Co Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Daito Pharmaceutical Co Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Daito Pharmaceutical Co Deferred Tax Related Terms

Thank you for viewing the detailed overview of Daito Pharmaceutical Co's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Daito Pharmaceutical Co (TSE:4577) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daito Pharmaceutical Co Ltd (TSE:4577) » Definitions » Deferred Tax
Comparable Companies
TSE:9273 TSE:4595 TSE:4554 TSE:2929 TSE:4538 TSE:4574 TSE:4886 TSE:4582 TSE:4524 TSE:4512 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
326 Yokamachi, Toyama, JPN, 939-8567
Website
http://www.daitonet.co.jp
Daito Pharmaceutical Co Ltd is engaged in the research and development of pharmaceutical products. The company also undertakes contract manufacturing.

Daito Pharmaceutical Co (TSE:4577) Headlines

No Headlines